A Joint Front
"An open source drug discovery programme allows capabilities to be linked and used, at negligible cost. India has already taken a step in this direction," says Samir K Brahmachari, Founder Director, CSIR IGIB, and Former Director General, CSIR.
Why do we continue to have an Ola after Uber or a Flipkart after Amazon, and not the other way? One possible answer could be that we are comfortable with status quo and hence, despite being smart, not keen to innovate.
Another probable reason could be that even if we are keen, our present ecosystem does not encourage disruptive risk taking projects. As someone who has helped design India's own disruptive programme in innovation an open source drug discovery programme (OSDD) I would believe that disruptive innovations do happen in
